Ning Guo

6PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 13, 2025
Nuclear PD-L1 drives IFN-γ-promoted lung metastasis of triple-negative breast cancer via POLR2A-mediated transcriptional activation of LY6E.

Xu Wang, Qi Zhou, Pu Wang

|Apr 20, 2024
Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial.

Ming Shi, Jiaojiao Wang, Hongming Huang

|Jan 08, 2021
Blockade of AIM2 inflammasome or α1-AR ameliorates IL-1β release and macrophage-mediated immunosuppression induced by CAR-T treatment.

Dan Liu, Xiyue Xu, Yulian Dai

|Oct 05, 2020
β2-AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells.

Dan Liu, Li Zha, Yuchen Liu

|Sep 24, 2017
Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating β-adrenergic signaling.

Hongyu Chen, Dan Liu, Liang Guo

|May 13, 2017
β2-AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells.

Hongyu Chen, Wei Zhang, Xiang Cheng

Pageof 1

Frequent Collaborators

2 joint publications

Junnian Zheng

1 joint publications

Hongming Huang

1 joint publications

Dan Liu

1 joint publications

Wei Chen